|
Volumn 12, Issue 16, 2002, Pages 2125-2128
|
Identification of a novel 1′-[5-((3,5-Dichlorobenzoyl)methylamino)-3-(3,4-dichlorophenyl)-4- (methoxyimino)pentyl]-2-oxo-(1,4′-bipiperidine) as a Dual NK1/NK2 antagonist
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1' [5 [(3,5 DICHLOROBENZOYL)METHYLAMINO] 3 (3,4 DICHLOROPHENYL) 4 (METHOXYIMINO)PENTYL] 2 OXO (1,4' DIPIPERIDINE);
NEUROKININ 1 RECEPTOR ANTAGONIST;
NEUROKININ 2 RECEPTOR ANTAGONIST;
PIPERIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
NEUROKININ 1 RECEPTOR;
NEUROKININ 2 RECEPTOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DOG;
DRUG ACTIVITY;
DRUG BLOOD LEVEL;
DRUG POTENCY;
GUINEA PIG;
IN VIVO STUDY;
NONHUMAN;
ANIMAL;
AREA UNDER THE CURVE;
BLOOD;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG ANTAGONISM;
DRUG SCREENING;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
CANIS FAMILIARIS;
ANIMALS;
AREA UNDER CURVE;
DOGS;
DRUG EVALUATION, PRECLINICAL;
GUINEA PIGS;
MOLECULAR STRUCTURE;
PIPERIDINES;
RECEPTORS, NEUROKININ-1;
RECEPTORS, NEUROKININ-2;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0037136002
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(02)00340-2 Document Type: Article |
Times cited : (5)
|
References (15)
|